Medtronic plc is a leading global healthcare technology company focused on innovating medical devices, digital health solutions, and therapies to improve human health.

# Medtronic plc - Company Overview

## Business Description
- **Type:** Global healthcare technology company
- **Founded:** 1949
- **Headquarters:** Galway, Ireland
- **Presence:** Serves healthcare systems, physicians, clinicians, and patients in **more than 150 countries**

## Mission
- **Core Mission:** "To contribute to human welfare by applying biomedical engineering in research, design, manufacture, and sale of products to **alleviate pain, restore health, and extend life.**"
- **Strategic Focus:**
  - Accelerate innovation-driven growth with attractive markets and robust pipeline
  - Deliver superior health outcomes and better experiences for patients and providers
  - Leverage data, artificial intelligence (AI), and automation for real-time therapies and care

## Workforce and Market
- **Number of Employees:** Over **95,000 full-time employees**
  - **44% based in the U.S. or Puerto Rico**
- **Revenue (Market Valuation):**
  - **Market value of voting and non-voting common equity held by non-affiliates:** Approximately **$116.2 billion** (as of October 25, 2024)
- **Outstanding Shares:** Approximately **1.28 billion** (as of June 17, 2025)

## Business Segments and Operations
- **Segment Types:**
  - **Cardiovascular Portfolio**
  - **Neuroscience Portfolio**
  - **Medical Surgical Portfolio**
  - **Diabetes Operating Unit**
- **Products and Services:**
  - **Device-based therapies** primarily for cardiovascular, neurological, surgical, and diabetes care
  - **Software, digital solutions, and AI integration** to improve treatment and healthcare delivery

## Key Focus Areas
1. **Innovation & Growth:**
   - Launching new products, expanding pipeline, integrating AI and data analytics
2. **Patient and Provider Outcomes:**
   - Creating simpler, effective therapies with deep insights
3. **Global Expansion:**
   - Increasing adoption globally, especially in international markets
4. **Technology Integration:**
   - Incorporating AI, remote monitoring, and real-time therapy customization

## Financial Highlights (Fiscal Year Ended April 25, 2025)
- **Net Sales:** Approximately **$33.54 billion**
- **Operating Income (Net Income):** 
  - **$4.66 billion** (GAAP)
  - **$7.08 billion** (non-GAAP, excluding certain charges)
- **Diluted Earnings Per Share (EPS):**
  - **$3.61** (GAAP)
  - **$5.49** (non-GAAP)
- **Revenue Growth:** 4% increase from previous year
- **Market Valuation:** ~$116.2 billion (non-affiliates' market value)
- **Employees:** Over **95,000** full-time

## Key Initiatives
- Focus on developing innovative therapies (e.g., minimally invasive surgical tools, advanced cardiac devices, neurostimulation systems, diabetes management tech)
- Separation planned for the Diabetes business (expected completion within 18 months of May 2025 announcement)
- Share repurchase programs, with approximately **38 million shares** bought back in FY2025

---

This summary provides a detailed overview of Medtronic's core business operations, scale, financials, strategic focus, and product segments based solely on the provided document.

Medtronic plc is a leading global healthcare technology company focused on innovative medical therapies and device solutions in areas such as cardiovascular, neuroscience, medical surgical, and diabetes management.

# Medtronic plc: Company Overview

## Business Core
Medtronic plc is a leading global healthcare technology company founded in 1949 and headquartered in Dublin, Ireland. The company focuses on developing, manufacturing, distributing, and selling device-based medical therapies and services across several key segments:

1. **Cardiovascular Portfolio**
   - **Divisions**: Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, Coronary & Peripheral Vascular.
   - **Key Products**: 
     - Implantable cardiac pacemakers (e.g., Micra transcatheter pacing system).
     - Implantable cardioverter defibrillators (ICDs).
     - Cardiac resynchronization therapy devices (CRT-Ds and CRT-Ps).
     - Cardiac ablation products.
     - Remote monitoring services.
  
2. **Neuroscience Portfolio**
   - **Divisions**: Cranial & Spinal Technologies, Specialty Therapies, Neuromodulation.
   - **Key Products**:
     - Neurosurgery products (e.g., navigation systems, robotic guidance).
     - Neurovascular devices (e.g., coils, stent retrievers).
     - Spinal cord stimulation systems.
     - Brain modulation systems.

3. **Medical Surgical Portfolio**
   - **Divisions**: Surgical & Endoscopy, Acute Care & Monitoring.
   - **Key Products**:
     - Advanced surgical devices (e.g., stapling devices, electrosurgery products).
     - Patient monitoring systems.
     - Airway management products.

4. **Diabetes Operating Unit**
   - Focused on products and services for managing Type 1 and Type 2 diabetes.
   - **Key Products**:
     - Insulin pumps (e.g., MiniMed 780G system).
     - Continuous glucose monitoring systems (e.g., Guardian Connect CGM).
     - Smart insulin pen systems (e.g., InPen).

## Operational Scope
- **Geographic Reach**: Medtronic serves healthcare systems, physicians, clinicians, and patients in over 150 countries.
- **Customers**: The company's products are primarily used in hospitals, surgical centers, and other healthcare facilities, with no single customer representing more than 10% of total net sales.
  
## Workforce
- **Employees**: Medtronic employs over **95,000** full-time personnel, with approximately **44%** based in the U.S. or Puerto Rico.
- **Inclusion and Diversity**: Women constitute **51%** of the global workforce, and **41%** of the U.S. workforce is ethnically diverse.

## Financial Overview
- **Fiscal Year**: Specific fiscal year 2024 performance metrics are not detailed in the provided content. 
- **Revenue**: As of the last reported period, Medtronic's total revenue and specific income figures were not explicitly mentioned, requiring reference to financial statements for accurate metrics. 
- **Shareholder Value**: The company aims to enhance shareholder value while accelerating innovation-driven growth.

## Research & Development
- Medtronic is committed to investing in R&D and maintaining technological leadership, which includes hundreds of clinical trials annually to address unmet patient needs and reduce healthcare costs.

## Conclusion
Medtronic plc stands out as a comprehensive player in the medical device industry, striving to improve patient outcomes through innovative technologies while ensuring a strong commitment to corporate responsibility, diversity, and equity.

Medtronic plc

10-K / June 20, 2025

10-K / June 20, 2024

10-K / June 20, 2025

Medtronic plc - Company Overview

Business Description

Mission

Workforce and Market

Business Segments and Operations

Key Focus Areas

Financial Highlights (Fiscal Year Ended April 25, 2025)

Key Initiatives